As of June 17, 2025, Medifast Inc (MED) reports a Net Margin of 0.35%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Medifast Inc's Net Margin
Over recent years, Medifast Inc's Net Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-12-31 | 0.35% |
| 2023-12-31 | 9.27% |
| 2022-12-31 | 8.98% |
| 2021-12-31 | 10.75% |
| 2020-12-31 | 11.01% |
This slight downward trend highlights how Medifast Inc manages its overall profitability and cost control over time.
Comparing Medifast Inc's Net Margin to Peers
To better understand Medifast Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Medifast Inc (MED) | 0.35% |
| China Zhong Qi Holdings Ltd (CHZQ) | 57.41% |
| China Botanic Pharmaceutical Inc (CBPI) | 35.65% |
| Inter Parfums Inc (IPAR) | 11.32% |
| Scott's Liquid Gold-Inc (SLGD) | 11.17% |
| elf Beauty Inc (ELF) | 8.53% |
Compared to its competitors, Medifast Inc's Net Margin is about average compared to peers, reflecting typical industry profitability.